JPWO2022183052A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022183052A5 JPWO2022183052A5 JP2023552146A JP2023552146A JPWO2022183052A5 JP WO2022183052 A5 JPWO2022183052 A5 JP WO2022183052A5 JP 2023552146 A JP2023552146 A JP 2023552146A JP 2023552146 A JP2023552146 A JP 2023552146A JP WO2022183052 A5 JPWO2022183052 A5 JP WO2022183052A5
- Authority
- JP
- Japan
- Prior art keywords
- capsid
- raav
- vector
- promoter
- itr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163154485P | 2021-02-26 | 2021-02-26 | |
| US63/154,485 | 2021-02-26 | ||
| PCT/US2022/017998 WO2022183052A1 (en) | 2021-02-26 | 2022-02-25 | Composition and methods for the treatment of fabry disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024509792A JP2024509792A (ja) | 2024-03-05 |
| JP2024509792A5 JP2024509792A5 (https=) | 2025-03-03 |
| JPWO2022183052A5 true JPWO2022183052A5 (https=) | 2025-03-03 |
Family
ID=80786597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023552146A Withdrawn JP2024509792A (ja) | 2021-02-26 | 2022-02-25 | ファブリー病の治療のための組成物及び方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20240175054A1 (https=) |
| EP (1) | EP4298227A1 (https=) |
| JP (1) | JP2024509792A (https=) |
| KR (1) | KR20230150836A (https=) |
| CN (1) | CN117321212A (https=) |
| AR (1) | AR124981A1 (https=) |
| AU (1) | AU2022227017A1 (https=) |
| BR (1) | BR112023016983A2 (https=) |
| CA (1) | CA3209673A1 (https=) |
| CL (1) | CL2023002530A1 (https=) |
| CO (1) | CO2023011012A2 (https=) |
| EC (1) | ECSP23072174A (https=) |
| IL (1) | IL305440A (https=) |
| MX (1) | MX2023009978A (https=) |
| PE (1) | PE20240806A1 (https=) |
| TW (1) | TW202302855A (https=) |
| WO (1) | WO2022183052A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025529884A (ja) * | 2022-08-25 | 2025-09-09 | 武田薬品工業株式会社 | ファブリー病の治療に使用するための組成物 |
| CN121002183A (zh) * | 2023-04-17 | 2025-11-21 | 杭州复因生物科技有限公司 | 用于基因治疗的组合物和方法 |
| WO2024236544A1 (en) | 2023-05-17 | 2024-11-21 | Takeda Pharmaceutical Company Limited | Pet tracer compounds for tracing alpha-galactosidase a and reaction intermediates, and methods of use |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
| US6268213B1 (en) | 1992-06-03 | 2001-07-31 | Richard Jude Samulski | Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy |
| US5869305A (en) | 1992-12-04 | 1999-02-09 | The University Of Pittsburgh | Recombinant viral vector system |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6204059B1 (en) | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US5741683A (en) | 1995-06-07 | 1998-04-21 | The Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
| WO1998046728A1 (en) | 1997-04-14 | 1998-10-22 | Cell Genesys, Inc. | Methods for increasing the efficiency of recombinant aav product |
| WO1999061643A1 (en) | 1998-05-27 | 1999-12-02 | University Of Florida | Method of preparing recombinant adeno-associated virus compositions by using an iodixananol gradient |
| ES2340230T3 (es) | 1998-11-10 | 2010-05-31 | University Of North Carolina At Chapel Hill | Vectores viricos y sus procedimientos de preparacion y administracion. |
| US7201898B2 (en) | 2000-06-01 | 2007-04-10 | The University Of North Carolina At Chapel Hill | Methods and compounds for controlled release of recombinant parvovirus vectors |
| NZ532635A (en) | 2001-11-13 | 2007-05-31 | Univ Pennsylvania | A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method |
| DK2359869T3 (en) | 2001-12-17 | 2019-04-15 | Univ Pennsylvania | Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof |
| AU2003274397A1 (en) | 2002-06-05 | 2003-12-22 | University Of Florida | Production of pseudotyped recombinant aav virions |
| CN1856576B (zh) | 2003-09-30 | 2011-05-04 | 宾夕法尼亚州立大学托管会 | 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用 |
| WO2006110689A2 (en) | 2005-04-07 | 2006-10-19 | The Trustees Of The University Of Pennsylvania | Method of increasing the function of an aav vector |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| US20120322861A1 (en) | 2007-02-23 | 2012-12-20 | Barry John Byrne | Compositions and Methods for Treating Diseases |
| US9249425B2 (en) | 2011-05-16 | 2016-02-02 | The Trustees Of The University Of Pennslyvania | Proviral plasmids and production of recombinant adeno-associated virus |
| EP3794131A4 (en) * | 2018-05-15 | 2022-01-26 | University of Massachusetts | RAAV VECTORS ENCODING FOR LYSOSOMAL BETA-GALACTOSIDASE (GLB1) AND CATHEPSIN A |
| AR116624A1 (es) * | 2018-10-10 | 2021-05-26 | Amicus Therapeutics Inc | Composiciones de polipéptidos estabilizados por enlaces disulfuro y métodos de uso |
| US12454701B2 (en) * | 2018-12-05 | 2025-10-28 | Abeona Therapeutics Inc. | Recombinant adeno-associated viral vector for gene delivery |
| SG11202106348QA (en) * | 2018-12-20 | 2021-07-29 | Codexis Inc | Human alpha-galactosidase variants |
| JP7716338B2 (ja) * | 2019-01-04 | 2025-07-31 | サンガモ セラピューティクス， インコーポレイテッド | ファブリー病の処置のための方法及び組成物 |
| AU2021356684A1 (en) * | 2020-10-09 | 2023-05-11 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of fabry disease |
-
2022
- 2022-02-25 KR KR1020237032457A patent/KR20230150836A/ko active Pending
- 2022-02-25 IL IL305440A patent/IL305440A/en unknown
- 2022-02-25 PE PE2023002431A patent/PE20240806A1/es unknown
- 2022-02-25 CN CN202280030576.5A patent/CN117321212A/zh active Pending
- 2022-02-25 AR ARP220100423A patent/AR124981A1/es unknown
- 2022-02-25 CA CA3209673A patent/CA3209673A1/en active Pending
- 2022-02-25 EP EP22711380.0A patent/EP4298227A1/en active Pending
- 2022-02-25 MX MX2023009978A patent/MX2023009978A/es unknown
- 2022-02-25 WO PCT/US2022/017998 patent/WO2022183052A1/en not_active Ceased
- 2022-02-25 BR BR112023016983A patent/BR112023016983A2/pt not_active Application Discontinuation
- 2022-02-25 US US18/547,809 patent/US20240175054A1/en active Pending
- 2022-02-25 TW TW111107143A patent/TW202302855A/zh unknown
- 2022-02-25 JP JP2023552146A patent/JP2024509792A/ja not_active Withdrawn
- 2022-02-25 AU AU2022227017A patent/AU2022227017A1/en not_active Abandoned
-
2023
- 2023-08-24 CO CONC2023/0011012A patent/CO2023011012A2/es unknown
- 2023-08-25 CL CL2023002530A patent/CL2023002530A1/es unknown
- 2023-09-22 EC ECSENADI202372174A patent/ECSP23072174A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021087431A5 (https=) | ||
| US20220331409A1 (en) | Factor ix gene therapy | |
| Baruteau et al. | Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects | |
| JP2024009857A5 (https=) | ||
| JP2019116492A5 (https=) | ||
| JP2021106619A5 (https=) | ||
| JP2021003120A5 (https=) | ||
| WO2016100575A1 (en) | Gene therapy for juvenile batten disease | |
| JP2024099770A5 (https=) | ||
| US20260062682A1 (en) | Aav-mediated gene therapy for maple syrup urine disease (msud) | |
| JPWO2020106916A5 (https=) | ||
| JPWO2021067448A5 (https=) | ||
| JP2021520811A5 (https=) | ||
| JP2023065516A5 (https=) | ||
| KR20250115422A (ko) | 반복적 요소의 적절한 패키징을 위한 아데노 연관 바이러스 벡터 | |
| RU2019130004A (ru) | Генная терапия при глазных заболеваниях | |
| JPWO2021050614A5 (https=) | ||
| JPWO2022183052A5 (https=) | ||
| JPWO2021014428A5 (https=) | ||
| JPWO2021076911A5 (https=) | ||
| JP2025515356A5 (https=) | ||
| JPWO2020237130A5 (https=) | ||
| JPWO2019200286A5 (https=) | ||
| Gray et al. | Vector design and considerations for CNS applications | |
| JPWO2022166954A5 (https=) |